Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 21, 2016

Study Completion Date

May 5, 2017

Conditions
ProteinuriaIdiopathic Membranous Nephropathy
Interventions
DRUG

Repository Corticotropin Injection

Acthar given SC for 6 months

DRUG

Placebo

"Placebo contains the same inactive ingredients as that used for H.P. Acthar Gel without the API.~Placebo given SC for 6 months (80 U two times a week)."

Trial Locations (28)

10032

Mallinckrodt Investigational Site, New York

18017

Mallinckrodt Investigational Site, Bethlehem

27599

Mallinckrodt Investigational Site, Chapel Hill

27705

Mallinckrodt Investigational Site, Durham

29425

Mallinckrodt Investigational Site, Charleston

30322

Mallinckrodt Investigational Site, Atlanta

32209

Mallinckrodt Investigational Site, Jacksonville

37404

Mallinckrodt Investigational Site, Chattanooga

55905

Mallinckrodt Investigational Site, Rochester

77030

Mallinckrodt Investigational Site, Houston

79430

Mallinckrodt Investigational Site, Lubbock

89502

Mallinckrodt Investigational Site, Reno

94304

Mallinckrodt Investigational Site, Stanford

95825

Mallinckrodt Investigational Site, Sacramento

M5G 2N2

Mallinckrodt Investigational Site, Toronto

Unknown

Mallinckrodt Investigational Site, La Serena

Mallinckrodt Investigational Site, Temuco

Mallinckrodt Investigational Site, Monterrey

Mallinckrodt Investigational Site, San Nicolás de los Garza

Mallinckrodt Investigational Site 307, Adana

Mallinckrodt Investigational Site 305, Ankara

Mallinckrodt Investigational Site 308, Ankara

Mallinckrodt Investigational Site 302, Antalya

Mallinckrodt Investigational Site 301, Istanbul

Mallinckrodt Investigational Site 309, Istanbul

Mallinckrodt Investigational Site 303, Izmir

Mallinckrodt Investigational Site 310, Kocaeli

Mallinckrodt Investigational Site 304, Mersin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mallinckrodt

INDUSTRY

NCT01386554 - Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients | Biotech Hunter | Biotech Hunter